TY  - JOUR
AU  - van der Zanden, Loes F M
AU  - Vermeulen, Sita H
AU  - Oskarsdottir, Arna
AU  - Maurits, Jake S F
AU  - Diekstra, Meta H M
AU  - Ambert, Valentin
AU  - Cambon-Thomsen, Anne
AU  - Castellano, Daniel
AU  - Fritsch, Achim
AU  - Garcia Donas, Jesus
AU  - Guarch Troyas, Rosa
AU  - Guchelaar, Henk-Jan
AU  - Hartmann, Arndt
AU  - Hulsbergen-van de Kaa, Christina
AU  - Jaehde, Ulrich
AU  - Junker, Kerstin
AU  - Martinez-Cardus, Anna
AU  - Masson, Gisli
AU  - Oosterwijk-Wakka, Jeannette
AU  - Radu, Marius T
AU  - Rafnar, Thorunn
AU  - Rodriguez Antona, Cristina
AU  - Roessler, Max
AU  - Ruijtenbeek, Rob
AU  - Stefansson, Kari
AU  - Warren, Anne
AU  - Wessels, Lodewyk
AU  - Eisen, Tim
AU  - Kiemeney, Lambertus A L M
AU  - Oosterwijk, Egbert
PY  - 2017
DO  - 10.1016/j.urolonc.2017.03.009
SN  - 10781439
UR  - http://hdl.handle.net/20.500.12105/7437
AB  - OBJECTIVE: For patients with metastatic renal cell cancer (mRCC), treatment choice is mainly based on clinical parameters. With many treatments available and the limited response to treatment and associated toxicities, there is much interest in...
LA  - eng
PB  - Elsevier
KW  - Biomarker
KW  - Genomics
KW  - Metastatic renal cell carcinoma
KW  - Therapy response
KW  - Transcriptomics
KW  - Tyrosine kinase inhibitor
KW  - Adult
KW  - Aged
TI  - Description of the EuroTARGET cohort: A European collaborative project on TArgeted therapy in renal cell cancer-GEnetic- and tumor-related biomarkers for response and toxicity
TY  - journal article
ER  -